These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12764629)

  • 1. Long-term outcome of hydrocephalus management in myelomeningoceles.
    Tuli S; Drake J; Lamberti-Pasculli M
    Childs Nerv Syst; 2003 Jun; 19(5-6):286-91. PubMed ID: 12764629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
    Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
    Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.
    Tuli S; Drake J; Lawless J; Wigg M; Lamberti-Pasculli M
    J Neurosurg; 2000 Jan; 92(1):31-8. PubMed ID: 10616079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shunt infection and malfunction in patients with myelomeningocele.
    White MD; McDowell MM; Agarwal N; Greene S
    J Neurosurg Pediatr; 2021 May; 27(5):518-524. PubMed ID: 33636695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reviewing the prognostic factors in myelomeningocele.
    Protzenko T; Bellas A; Pousa MS; Protzenko M; Fontes JM; de Lima Silveira AM; Sá CA; Pereira JP; Salomão RM; Salomão JFM; Dos Santos Gomes SC
    Neurosurg Focus; 2019 Oct; 47(4):E2. PubMed ID: 31574474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life.
    Paulsen AH; Lundar T; Lindegaard KF
    J Neurosurg Pediatr; 2015 Dec; 16(6):633-41. PubMed ID: 26359766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.
    Drake JM; Kestle JR; Milner R; Cinalli G; Boop F; Piatt J; Haines S; Schiff SJ; Cochrane DD; Steinbok P; MacNeil N
    Neurosurgery; 1998 Aug; 43(2):294-303; discussion 303-5. PubMed ID: 9696082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study.
    Riva-Cambrin J; Kestle JR; Holubkov R; Butler J; Kulkarni AV; Drake J; Whitehead WE; Wellons JC; Shannon CN; Tamber MS; Limbrick DD; Rozzelle C; Browd SR; Simon TD;
    J Neurosurg Pediatr; 2016 Apr; 17(4):382-90. PubMed ID: 26636251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience in shunt management on revision free survival in infants with myelomeningocele.
    Al-Hakim S; Schaumann A; Schneider J; Schulz M; Thomale UW
    Childs Nerv Syst; 2018 Jul; 34(7):1375-1382. PubMed ID: 29582171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of death in pediatric patients requiring cerebrospinal fluid shunts.
    Tuli S; Tuli J; Drake J; Spears J
    J Neurosurg; 2004 May; 100(5 Suppl Pediatrics):442-6. PubMed ID: 15287452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the risk of a shunt malfunction after elective intradural surgery?
    Venable GT; Green CS; Smalley ZS; Bedford EC; Modica JS; Klimo P
    J Neurosurg Pediatr; 2015 Dec; 16(6):642-7. PubMed ID: 26359674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results of hydrocephalus with myelomeningocele].
    Kojima N; Tamaki N; Matsumoto S
    No To Shinkei; 1990 Sep; 42(9):879-88. PubMed ID: 2245084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Hydrocephalus in Ethiopia: Treatment Failures and Infections: A Hospital-Based, Retrospective Study.
    Laeke T; Tirsit A; Biluts H; Murali D; Wester K
    World Neurosurg; 2017 Apr; 100():30-37. PubMed ID: 28057596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward reducing shunt placement rates in patients with myelomeningocele.
    Chakraborty A; Crimmins D; Hayward R; Thompson D
    J Neurosurg Pediatr; 2008 May; 1(5):361-5. PubMed ID: 18447669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation and surveillance imaging of children with myelomeningocele and shunted hydrocephalus: a follow-up study.
    Wetzel JS; Heaner DP; Gabel BC; Tubbs RS; Chern JJ
    J Neurosurg Pediatr; 2019 Feb; 23(2):153-158. PubMed ID: 30497223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele.
    Phillips BC; Gelsomino M; Pownall AL; Ocal E; Spencer HJ; O'Brien MS; Albert GW
    J Neurosurg Pediatr; 2014 Aug; 14(2):167-72. PubMed ID: 24877604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shunt complications in the first postoperative year in children with meningomyelocele.
    Caldarelli M; Di Rocco C; La Marca F
    Childs Nerv Syst; 1996 Dec; 12(12):748-54. PubMed ID: 9118142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of cerebrospinal fluid shunt antisiphon devices.
    da Silva MC; Drake JM
    Pediatr Neurosurg; 1991-1992; 17(6):304-9. PubMed ID: 1840818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.
    Meling TR; Egge A; Due-Tønnessen B
    Pediatr Neurosurg; 2005; 41(1):8-14. PubMed ID: 15886507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter prospective cohort study of the Strata valve for the management of hydrocephalus in pediatric patients.
    Kestle JR; Walker ML;
    J Neurosurg; 2005 Mar; 102(2 Suppl):141-5. PubMed ID: 16156221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.